info icon

This is a non-core endpoint: only basic statistics are computed.

!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced

PHLEB_VENAE_ILIAC_EXTER

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ATC codes for adverse effects of Drugs ANY
  • Hospital discharge: ICD-10 I80.20#

1 out of 7 registries used, show all original rules.

15

4. Check minimum number of events

None

15

5. Include endpoints

None

15

6. Filter based on genotype QC (FinnGen only)

15

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
C
First used in FinnGen datafreeze
DF5

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

This endpoint is excluded (not available in FinRegistry).

-FinnGen-

Key figures

All Female Male
Number of individuals 15 10 5
Unadjusted period prevalence (%) 0.00 0.00 0.00
Median age at first event (years) 53.42 51.90 56.46

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

No data available

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(1761868) Lipid panel - Serum or Plasma
6
32
2.44
0.94
2.2
3.6
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
7
41
2.31
0.86
2.0
1.7
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
5
28
2.17
0.74
2.4
3.0
mg/l
17.7
97.5
—
5
21
(3013512) EKG study
6
35
2.18
0.68
2.3
4.9
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
5
33
1.77
0.47
5.2
2.6
ng/l
7.5
179.9
—
5
23
(3037522) Nuclear Ab [Titer] in Serum
0
15
0.00
0.44
0.0
1.3
—
506.7
—
0
6
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
0
14
0.00
0.43
0.0
3.4
—
22.5
—
0
8
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
8
62
1.62
0.38
2.4
3.1
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
5
38
1.47
0.27
3.8
4.7
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
9
76
1.46
0.23
3.3
3.9
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
0
10
0.00
0.22
0.0
1.3
—
—
—
0
0
(3012544) pH of Venous blood
0
10
0.00
0.22
0.0
2.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
7
76
0.85
0.10
3.0
2.7
u/l
25.6
55.3
—
7
71
(3000991) Gas panel - Venous blood
0
7
0.00
0.00
0.0
3.7
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
3.4
—
1.3
—
0
5
(40768443) Skin Pathology biopsy report
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
2.5
—
0
5
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
0.4
—
0
7
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
3.4
—
0.0
—
0
5
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
0
5
0.00
0.00
0.0
3.8
—
1.7
—
0
5
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
3.4
—
0.0
—
0
5
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
0
6
0.00
0.00
0.0
2.8
—
4.7
—
0
6
(1761482) Bacteria [#/volume] in Urine by Culture
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
0
5
0.00
0.00
0.0
4.2
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
0
9
0.00
0.00
0.0
2.3
—
5.9
—
0
9
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
0
7
0.00
0.00
0.0
2.7
—
—
—
0
0
(3003338) MCHC [Mass/volume]
9
94
0.89
0.00
18.7
19.8
g/l
333.2
331.9
—
9
94
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
3.4
—
0.0
—
0
5
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
0
5
0.00
0.00
0.0
2.8
—
3.2
—
0
5
(3004588) Protein electrophoresis panel - Serum or Plasma
0
9
0.00
0.00
0.0
2.4
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
0
5
0.00
0.00
0.0
2.8
—
84.7
—
0
5

Mortality – FinRegistry

This endpoint is excluded (not available in FinRegistry).

Relationships between endpoints

Index endpoint: PHLEB_VENAE_ILIAC_EXTER – !Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced

GWS hits: -

This endpoint is excluded (not available in FinRegistry).